# OnCo record cd22 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/cd22/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "cd22" ;
  schema:name "CD22"@en ;
  schema:description "CD22 is a B-cell surface protein and the docking site for the leukaemia ADC inotuzumab ozogamicin."@en ;
  schema:url <https://onco.cc/targets/cd22/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/CD22>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1643>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000012124>, <https://www.uniprot.org/uniprotkb/P20273/entry>, <https://www.ncbi.nlm.nih.gov/gene/933> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5009798> ;
  schema:citation <https://en.wikipedia.org/wiki/CD22>, <https://doi.org/10.1038/nature08638> ;
  onco:tag "adc-target", "car-t-target" ;
  schema:alternateName "CD22" ;
  onco:targetClass "surface-antigen" ;
  onco:firstDescribed "1990"^^xsd:gYear ;
  onco:related <https://onco.cc/biomarkers/cd22-expression/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/inotuzumab-ozogamicin/>, <https://onco.cc/drugs/ucart22/>, <https://onco.cc/drugs/azd4512/> .